Nanion and Axiogenesis present parallel patch clamp recordings of action potentials from Cor.At cardiomyocytes
Stem cell derived cardiomyocytes have tremendous potential for cardiac safety testing of drug candidates. By offering an…
Stem cell derived cardiomyocytes have tremendous potential for cardiac safety testing of drug candidates. By offering an…
The SyncroPatch 96, a high quality, high throughput patch clamp ion channel screening platform, shows impressive results…
Nanion gibt heute die Entwicklung des SyncroPatch 96 bekannt, eine neue, hoch-parallele Patch Clamp Plattform. Das Messs…